Samantha Marie-dubay Bickford, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 582 Roosevelt Trl, Windham, ME 04062 Phone: 207-892-3233 |
Steven James Aiello, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 582 Roosevelt Trl, Windham, ME 04062 Phone: 207-892-3233 Fax: 207-893-0752 |
Deighton Lewis, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 409 Roosevelt Trl, Windham, ME 04062 Phone: 207-400-8600 |
Sarah Rosemary Buchanan, MPAS, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 409 Roosevelt Trl, Windham, ME 04062 Phone: 207-857-8400 |
News Archive
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
Providing access to an outpatient clinic isn't enough to keep some trauma patients who have been discharged from the hospital from returning to the emergency department (ED) for follow-up care, even for such minor needs as pain medication refills and dressing changes, according to new Johns Hopkins research.
GenomeNext, LLC, a leader in genomic data management and integrated analysis, announced today that, through the "Intel Heads In The Clouds Challenge on Amazon Web Services" with support from JHC Technology, and in conjunction with Nationwide Children's Hospital, has benchmarked whole genome sequencing analysis at an unprecedented 1,000 genomes per day.
HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report its third quarter 2013 financial and operating results at 8:00 a.m. Central/9:00 a.m. Eastern on Friday, November 8, 2013. Supplemental financial information including the press release and presentation will be available at http://investor.hms.com/events.cfm at approximately 7:30 a.m. Eastern on November 8.
MAKO Surgical Corp., a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced its operating results for its second quarter ended June 30, 2010.
› Verified 8 days ago